What is ALGN's health score?

ALIGN TECHNOLOGY INC (ALGN) has a TradeApes health score of 69 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ALGN's estimated fair value?

Based on our 5-year discounted cash flow model, ALIGN TECHNOLOGY INC's estimated fair value is $81.87 per share, representing a -51.4% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is ALGN undervalued or overvalued?

Our model currently rates ALGN as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for ALGN... Refresh in a moment for the full analysis.

ALIGN TECHNOLOGY INC (ALGN)

Healthcare Overvalued low healthy

$168.29

Updated: 2026-06-05

TradeApes Score

Financial Strength

75 Strong

Operating Trend

63 Healthy

Relative Value

65 Healthy

Capital Allocation

65 Healthy

Risk

80 Strong

Est. Fair Value $81.87

DCF Upside -51.4%

Sector Rank #4629 of 6567

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− High P/E — 25–45×, growth premium already priced in

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.